Profile
Substance use treatment; Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment; General Hospital (including VA hospital); Buprenorphine used in Treatment; Naltrexone used in Treatment; This facility administers/prescribes medication for alcohol use disorder; In-network prescribing entity; Buprenorphine detoxification; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Acamprosate (CampralĀ®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; 12-step facilitation; Private non-profit organization; State department of health; Hospital licensing authority; The Joint Commission; Medicare; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; Adult women; Adult men; Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Drug or alcohol urine screening; Aftercare/continuing care; Discharge Planning; Opioids detoxification; Medication routinely used during detoxification; Substance use disorder education; Group counseling; Family counseling; Smoking not permitted; Adults; Young adults; Female; Male; Sign language services for the deaf and hard of hearing; Vaping not permitted; Mental health services; Suicide prevention services